staff reporter

The company said it will use the funds to support commercialization of its Amperia system for automated protein quantitation.

DNA-containing extracellular vesicles appeared to help clear damaged DNA from tumor cells while providing antitumor information to immune cells.

DiaMex is a manufacturer of third-party serology and molecular quality controls for clinical laboratories and blood banks.

The trial done in collaboration with the Istituto Europeo di Oncologia will assess how the test influences oncologists' treatment plans for early-stage breast cancer patients.

The companies will combine technologies to provide tailored assays for pharma firms developing therapies for neurological and inflammatory diseases.

The Belgium biotech firm will use the funding to further develop its sterility test for biopharma, leveraging its silicon chip-based qPCR technology.

The cash raised brings the company’s total holdings to about $33 million, enough to see it through plans to gain reimbursement for its esophageal cancer test.

The TarCET Kit offers a suite of sequencing panels covering a range of genetic conditions including metabolic disorders, infertility, and cardiovascular diseases.

The guidance provides the agency's thoughts on the emerging use of ctDNA residual disease testing to select patients for treatment in trials of new adjuvant therapies.

Researchers uncovered 63 new or known risk loci for age-related macular degeneration using data for ancestrally diverse individuals enrolled in half a dozen prior studies.